Disclosed are substituted heterocycle compounds including substituted pyrazoles, substituted pyrimidines, and substitute triazoles. The substituted heterocycles disclosed herein are shown to be useful in inhibiting c-MYC and may be utilized as therapeutics for treating cancer and cell proliferative disorders.
本文披露了包括取代
吡唑、取代
嘧啶和取代三唑在内的取代
杂环化合物。本文披露的取代
杂环化合物已被证明在抑制c-MYC方面具有用途,并可用作治疗癌症和细胞增殖性疾病的治疗药物。